Chinook Therapeutics Inc (KDNY) · page 11 of 36
The slide functions as a critique of clinical trial data integrity, specifically focusing on the inclusion of serum creatinine doubling and the use of inulin as a gold standard.
Research note · appendix_methodology · expose_contradiction · balanced density
Slide locked Sign in to view
Slide schematic 4/4
paragraph 3/3 source-note 1/1
Components 4
paragraph paragraph paragraph source-note
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1